Guillaume Monneret
Immunology · 2013–2018
A researcher in the Science corpus: 3 papers; trusts 1 researcher and is trusted by 5 researchers here, as inferred from the citation graph.
Subfields
- Immunology — 49 citations into it; #674 of 2,160 by trust here, #1,346 by citations
- Epidemiology — 28 citations into it; #650 of 2,148 by trust here, #958 by citations
Whom Guillaume Monneret trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Who trusts Guillaume Monneret overall
Papers from Guillaume Monneret's perspective
Ordered by how strongly the researchers Guillaume Monneret trusts endorse each paper. Same corpus, a different order for every researcher.
- Drotrecogin alfa (activated) for adults with severe sepsis and a low risk of death. (New England Journal of Medicine)
- The Surviving Sepsis Campaign: results of an international guideline-based performance improvement program targeting severe sepsis (Intensive Care Medicine)
- Nonresolving inflammation. (Cell)
- Posttranscriptional control of T cell effector function by aerobic glycolysis. (Cell)
- Cancer Immunoediting: Integrating Immunity’s Roles in Cancer Suppression and Promotion (Science)
- The pathophysiology and treatment of sepsis. (New England Journal of Medicine)
- Fueling Immunity: Insights into Metabolism and Lymphocyte Function (Science)
- Autoimmune dilated cardiomyopathy in PD-1 receptor-deficient mice. (Science)
- PD-1 and its ligands in tolerance and immunity. (Annual Review of Immunology)
- Hydrocortisone therapy for patients with septic shock. (New England Journal of Medicine)
Their papers
- Advances in the understanding and treatment of sepsis-induced immunosuppression (2018) — 829 citations
- Immunosuppression in sepsis: a novel understanding of the disorder and a new therapeutic approach (2013) — 1,343 citations
- Sepsis-induced immunosuppression: from cellular dysfunctions to immunotherapy (2013) — 2,432 citations